AML with RUNX1-RUNX1T1, AML with some KMT2A fusions, and AML with three mutations (in NPM1, DNMT3A, and FLT3) together were also associated with mRNA and miRNA expression signatures. This evidence concerns the gene DNMT3A and acute myeloid leukemia.